Effect of Intramuscular Midazolam premedication on Anesthesia Satisfaction in Female Patients

Effect of Intramuscular Midazolam Premedication on Overall Anesthesia Satisfaction in Female General Anesthesia Patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0006002

Enrollment

140

Registered

2021-03-16

Start date

2021-03-17

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : For the intervention group, 0.05mg/kg of midazolam is administered by intramuscular injection right after arriving the pre-operative holding area. For the control group, an equal amount of sali

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: > Patients undergoing general anesthesia for elective surgery > Female > 19 - 65 years old > Americlan Society of Anesthesiologist physical status classification (ASA PS classification) I, II

Exclusion criteria

Exclusion criteria: - Day surgeries or emergency surgeries - ASA PS classification = III - Body mass index = 30 - airway obstruction or dyspnea (e.g. formerly diagnosed obstructive sleep apnea, myasthenia gravis) - Hypersensitivity to benzodiazepines - current administration of benzodiazepines for other reasons - Pregnant or nursing women - Hepatic dysfunction of CTP class C - Acute narrow angle glaucoma - Inability to communicate because of cognitive impairment - Patients who cannot understand the consent form

Design outcomes

Primary

Measure	Time frame
Overall satisfaction of anesthesia (NRS 0-4)	—

Secondary

Measure	Time frame
Safety profile(heart rate, blood pressure, incidence of hypoxia);duration of recovery;postoperastive pain (NRS-10);Administration of rescue anti-emetics	—

Countries

Korea, Republic of

Contacts

Public ContactSeung Woo Song

Yonsei University

googlfong@gmail.com+82-33-741-1536

Outcome results